These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29179687)

  • 41. Fecal Microbiota Transplantation for Primary Clostridium difficile Infection.
    Juul FE; Garborg K; Bretthauer M; Skudal H; Øines MN; Wiig H; Rose Ø; Seip B; Lamont JT; Midtvedt T; Valeur J; Kalager M; Holme Ø; Helsingen L; Løberg M; Adami HO
    N Engl J Med; 2018 Jun; 378(26):2535-2536. PubMed ID: 29860912
    [No Abstract]   [Full Text] [Related]  

  • 42. Faecal microbiota transplantation for Clostridium difficile infection.
    Dodin M; Katz DE
    Int J Clin Pract; 2014 Mar; 68(3):363-8. PubMed ID: 24372725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Faecal transplantation for the treatment of Clostridium difficile infection in a marmoset.
    Yamazaki Y; Kawarai S; Morita H; Kikusui T; Iriki A
    BMC Vet Res; 2017 May; 13(1):150. PubMed ID: 28569200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does the donor matter? Donor vs patient effects in the outcome of a next-generation microbiota-based drug trial for recurrent Clostridium difficile infection.
    Ray A; Jones C
    Future Microbiol; 2016 May; 11():611-6. PubMed ID: 26986546
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term microbiota and virome in a Zürich patient after fecal transplantation against Clostridium difficile infection.
    Broecker F; Klumpp J; Moelling K
    Ann N Y Acad Sci; 2016 May; 1372(1):29-41. PubMed ID: 27286042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease.
    Seekatz AM; Theriot CM; Molloy CT; Wozniak KL; Bergin IL; Young VB
    Infect Immun; 2015 Oct; 83(10):3838-46. PubMed ID: 26169276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Moving fecal microbiota transplantation into the mainstream.
    Orenstein R; Griesbach CL; DiBaise JK
    Nutr Clin Pract; 2013 Oct; 28(5):589-98. PubMed ID: 23979974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin.
    Konturek PC; Haziri D; Helfritzsch H; Hess T; Harsch IA
    Med Princ Pract; 2017; 26(2):182-184. PubMed ID: 27978522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ethical implications of recruiting universal stool donors for faecal microbiota transplantation.
    Mikail M; O'Doherty KC; Poutanen SM; Hota SS
    Lancet Infect Dis; 2020 Mar; 20(3):e44-e49. PubMed ID: 31784367
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis?
    Tang G; Yin W; Liu W
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):322-329. PubMed ID: 28602517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Fecal transplantation for the treatment of relapsing diarrhea associated with Clostridium difficile infection in a liver transplantation patient].
    Múñez E; Ramos A; Baños I; Cuervas-Mons V
    Med Clin (Barc); 2016 Jan; 146(1):e3-4. PubMed ID: 26343156
    [No Abstract]   [Full Text] [Related]  

  • 52. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection.
    De Leon LM; Watson JB; Kelly CR
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1036-8. PubMed ID: 23669309
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Fecal microbiota transplantation in recurrent Clostridium difficile infections. Framework and pharmaceutical preparation aspects].
    Batista R; Kapel N; Megerlin F; Chaumeil JC; Barbut F; Bourlioux P; Chast F
    Ann Pharm Fr; 2015 Sep; 73(5):323-31. PubMed ID: 25825054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI).
    Jiang ZD; Alexander A; Ke S; Valilis EM; Hu S; Li B; DuPont HL
    Anaerobe; 2017 Dec; 48():110-114. PubMed ID: 28801119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients.
    Di Bella S; Gouliouris T; Petrosillo N
    J Infect Chemother; 2015 Apr; 21(4):230-7. PubMed ID: 25703532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. First Occurrence of Severe Extraintestinal Manifestations of Crohn's Disease Following Faecal Microbiota Transplantation.
    Teich N; Weber M; Stallmach A
    J Crohns Colitis; 2016 Oct; 10(10):1254-5. PubMed ID: 27056946
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes.
    Anand R; Song Y; Garg S; Girotra M; Sinha A; Sivaraman A; Phillips L; Dutta SK
    Dig Dis Sci; 2017 Apr; 62(4):1002-1008. PubMed ID: 28181098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clostridium difficile and cystic fibrosis: management strategies and the role of faecal transplantation.
    Dunwoody R; Steel A; Landy J; Simmonds N
    Paediatr Respir Rev; 2018 Mar; 26():16-18. PubMed ID: 28411069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year cohort study: authors' reply.
    Ianiro G; Sanguinetti M; Gasbarrini A; Cammarota G
    Clin Microbiol Infect; 2017 Nov; 23(11):891. PubMed ID: 28502839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.